Fox Run Management, L.L.C. Pacific Biosciences Of California, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.52 - $9.59 $3,717 - $10,127	1,056 Added 4.11%	26,744 $100,000
Q4 2023 Feb 13, 2024	BUY	$5.97 - $10.36 $17,342 - $30,095	2,905 Added 12.75%	25,688 $251,000
Q3 2023 Nov 07, 2023	BUY	$8.23 - $13.93 $187,504 - $317,367	22,783 New	22,783 $190,000
Q4 2022 Feb 07, 2023	BUY	$5.67 - $11.2 $100,863 - $199,236	17,789 New	17,789 $145,000
Q2 2022 Aug 12, 2022	BUY	$4.02 - $10.43 $56,975 - $147,824	14,173 New	14,173 $63,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.